Nicole Calakos
Lincoln Financial Group Distinguished Professor of Neurobiology
Links
Overview
Calakos, N. “Botulinum toxin: From molecule to clinic.” Handbook of Dystonia, 2006, pp. 343–54.
Shroff, Kunal, et al. “Dataset on the mass spectrometry-based proteomic profiling of mouse embryonic fibroblasts from a wild type and DYT-TOR1A mouse model of dystonia, basally and during stress.” Data Brief, vol. 39, Dec. 2021, p. 107609. Pubmed, doi:10.1016/j.dib.2021.107609. Full Text
Shroff, Kunal, et al. “DYT-TOR1A subcellular proteomics reveals selective vulnerability of the nuclear proteome to cell stress.” Neurobiol Dis, vol. 158, Oct. 2021, p. 105464. Pubmed, doi:10.1016/j.nbd.2021.105464. Full Text
Caffall, Zachary F., et al. “The HIV protease inhibitor, ritonavir, corrects diverse brain phenotypes across development in mouse model of DYT-TOR1A dystonia.” Sci Transl Med, vol. 13, no. 607, Aug. 2021. Pubmed, doi:10.1126/scitranslmed.abd3904. Full Text
Helseth, Ashley R., et al. “Cholinergic neurons constitutively engage the ISR for dopamine modulation and skill learning in mice.” Science, vol. 372, no. 6540, Apr. 2021. Pubmed, doi:10.1126/science.abe1931. Full Text
Rahimpour, Shervin, et al. “Treatment of diaphragmatic dystonia with pallidal deep brain stimulation.” Bmj Case Rep, vol. 14, no. 3, Mar. 2021. Pubmed, doi:10.1136/bcr-2020-240510. Full Text
Isaacson, Stuart H., et al. “Prospective Home-use Study on Non-invasive Neuromodulation Therapy for Essential Tremor.” Tremor Other Hyperkinet Mov (N Y), vol. 10, Aug. 2020, p. 29. Pubmed, doi:10.5334/tohm.59. Full Text
Sanders, Laurie H., and Nicole Calakos. “Dopamine Metabolism May Have Unexpected Benefits for Mitochondrial Energy Production.” Mov Disord, vol. 35, no. 4, Apr. 2020, p. 562. Pubmed, doi:10.1002/mds.28005. Full Text
Lungu, Codrin, et al. “Defining research priorities in dystonia.” Neurology, vol. 94, no. 12, Mar. 2020, pp. 526–37. Pubmed, doi:10.1212/WNL.0000000000009140. Full Text
Wang, Xiaoting, et al. “Parvalbumin Interneurons of the Mouse Nucleus Accumbens are Required For Amphetamine-Induced Locomotor Sensitization and Conditioned Place Preference.” Neuropsychopharmacology, vol. 43, no. 5, Apr. 2018, pp. 953–63. Pubmed, doi:10.1038/npp.2017.178. Full Text
O’Hare, Justin, et al. “Recent Insights into Corticostriatal Circuit Mechanisms underlying Habits: Invited review for Current Opinions in Behavioral Sciences.” Curr Opin Behav Sci, vol. 20, Apr. 2018, pp. 40–46. Pubmed, doi:10.1016/j.cobeha.2017.10.001. Full Text
Pages
Calakos, Nicole. “From Good Habit to Bad: Corticostriatal Synaptic and Circuit Mechanisms in Habit and Compulsion.” Neuropsychopharmacology, vol. 40, NATURE PUBLISHING GROUP, 2015, pp. S38–39.
Jay, C. A., and N. Calakos. “Heroin inhalation and leukoencephalopathy: A case series from California.” Neurology, vol. 52, no. 6, LIPPINCOTT WILLIAMS & WILKINS, 1999, pp. A446–A446.
Calakos, N., et al. “Cortical manifestations of the osmotic myelinolysis syndrome identified by MRI.” Neurology, vol. 52, no. 6, LIPPINCOTT WILLIAMS & WILKINS, 1999, pp. A80–81.
PEVSNER, J., et al. “MOLECULAR MECHANISMS OF SYNAPTIC TRANSMISSION.” Faseb Journal, vol. 9, no. 6, FEDERATION AMER SOC EXP BIOL, 1995, pp. A1457–A1457.
CALAKOS, N., et al. “PROTEIN DOMAINS IMPORTANT FOR TARGETING OF THE SYNAPTIC VESICLE PROTEIN, VAMP.” Journal of Cellular Biochemistry, WILEY-LISS, 1993, pp. 279–279.
BENNETT, M. K., et al. “SYNTAXIN - A SYNAPTIC PROTEIN IMPLICATED IN DOCKING OF SYNAPTIC VESICLES AT PRESYNAPTIC ACTIVE ZONES.” Molecular Biology of the Cell, vol. 3, AMER SOC CELL BIOLOGY, 1992, pp. A3–A3.